MedPath

Interventions for Adolescent Obesity

Not Applicable
Completed
Conditions
Adolescent Obesity
Interventions
Behavioral: Activity Tracker
Registration Number
NCT03004378
Lead Sponsor
The University of Texas Medical Branch, Galveston
Brief Summary

This study will evaluate whether the short-term use of activity tracking devices improves short-term weight loss in adolescents. The investigators will evaluate whether weight loss translates into a change in obesity-related biomarkers associated with adolescent obesity. In addition, the investigators will report outcomes after the implementation of activity tracking devices in conjunction with an intense adolescent weight loss program.

Detailed Description

This study will evaluate the short-term use of activity tracking devices and their effects on short- and long-term weight loss in adolescents. The investigators plan to establish whether weight loss translates into a change in obesity-related biomarkers associated with adolescent obesity. Each participant with an activity tracking device will have the goal of reaching 10,000 steps per day, in addition to their individual fitness plan.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria

Ages 12-18 years BMI ≥ 95th percentile for age and sex group Participant able to read and understand English Willingness to be randomized to any condition

Exclusion Criteria

Inability to obtain informed parental consent and/or child assent Inability to participate in the program due to pre-existing conditions (e.g., paralysis, heart failure, severe autism or mental retardation, psychosis) Pregnancy Clinical judgment concerning safety Inability of the participant to speak English

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionActivity TrackerFitbit (activity tracker) + participants will receive the clinic standard of care which includes individual assessment and management by: a pediatric gastroenterologist, a pediatric surgeon, a dietitian, and a fitness instructor who are present at every visit.
Primary Outcome Measures
NameTimeMethod
Feasibility of the pilot trial will be measured by an attrition rate of ≤50%.18 weeks

We set a study attrition rate of participants at ≤50% as the feasibility measure for the study.

Secondary Outcome Measures
NameTimeMethod
Body mass index (BMI) (kg/m2)Change from 0 to 18 weeks

Absolute change in BMI

Weight (kg)Change from 0 to 18 weeks

Weight change

Change in obesity related biomarkersChange from 0 to 18 weeks

AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT: gamma glutamyl transferase; CRP: C reactive protein

Trial Locations

Locations (1)

University of Texas Medical Branch

🇺🇸

Galveston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath